4.6 Review

Role of Ceramidases in Sphingolipid Metabolism and Human Diseases

期刊

CELLS
卷 8, 期 12, 页码 -

出版社

MDPI
DOI: 10.3390/cells8121573

关键词

neutral ceramidase; ceramide accumulation; metabolic syndrome; insulin resistance; type 2 diabetes; Alzheimer's disease; inflammatory bowel disease

资金

  1. Kaohsiung Medical University [KMU-DK108004, KMU-TC108A03-0]
  2. Taiwanese Ministry of Science and Technology [107-2911-I-037-505, 107-2314-B-037-114-MY3, 107-2321-B-037-002-]

向作者/读者索取更多资源

Human pathologies such as Alzheimer's disease, type 2 diabetes-induced insulin resistance, cancer, and cardiovascular diseases have altered lipid homeostasis. Among these imbalanced lipids, the bioactive sphingolipids ceramide and sphingosine-1 phosphate (S1P) are pivotal in the pathophysiology of these diseases. Several enzymes within the sphingolipid pathway contribute to the homeostasis of ceramide and S1P. Ceramidase is key in the degradation of ceramide into sphingosine and free fatty acids. In humans, five different ceramidases are known-acid ceramidase, neutral ceramidase, and alkaline ceramidase 1, 2, and 3-which are encoded by five different genes (ASAH1, ASAH2, ACER1, ACER2, and ACER3, respectively). Notably, the neutral ceramidase N-acylsphingosine amidohydrolase 2 (ASAH2) shows considerable differences between humans and animals in terms of tissue expression levels. Besides, the subcellular localization of ASAH2 remains controversial. In this review, we sum up the results obtained for identifying gene divergence, structure, subcellular localization, and manipulating factors and address the role of ASAH2 along with other ceramidases in human diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据